Announcements
The Company’s Board of Directors resolved to convene the 2023 Annual General Shareholders’ Meeting (New Approval)
1.Date of the board of directors resolution:2023/05/08 2.General shareholders’ meeting date:2023/06/27 3.General shareholders’ meeting location: Masterlink Securities Education and Training Center (11F., No.97, Sec. 2, Dunhua S. Rd., Taipei City) …
Announcement of the Consolidated Financial Statements for the first quarter of 2023 were approved by the Board of Directors.
1.Date of the board of directors submitted or approved:2023/05/08 2.Date of the audit committee approved:2023/05/08 3.Start and end dates of financial reports or unaudited financial information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):2023/01/01~2023/03/31 …
Announcement on behalf of Amaran of not Distributing Dividends of 2022
1.Date of the board of directors resolution:2023/05/05 2.Type and monetary amount of dividend distribution: The Board of Directors of Amaran resolved not to distribute dividends of 2022. 3.Any other matters …
Announcement on behalf of Amaran that the BOD resolved to convene the 2023 Annual General Shareholders’ Meeting
1.Date of the board of directors resolution:2023/05/05 2.General shareholders’ meeting date:2023/06/20 3.General shareholders’ meeting location: 5th Floor, No.19, Shengyi 5th Rd., Zhubei City, Hsinchu County 4.Cause for convening the meeting …
OBI is invited to attend the“ 13th Taiwan CEO Week & Taiwan New Economy Day” (Investor meeting on air) held by QIC
1.Date of institutional investor conference:2023/04/26~2023/04/28 2.Time of institutional investor conference:10:00 3.Location of institutional investor conference:online conference (Taiwan) 4.Outline of institutional investor conference: OBI is invited to attend the“ 13th Taiwan …
OBI has filed the application of Phase I human clinical trial for COVID-19 vaccine, BCVax, to TFDA
1.Date of occurrence of the event:2023/03/31 2.New drug name or code:COVID-19 vaccine, BCVax 3.Indication: COVID-19 vaccine, BCVax, is composed of the Delta spike protein with nanoparticle saponins as adjuvant that …
Update the related information regarding the leased office space in Taipei Bioinnovation Park
1.Date of occurrence of the event:2023/03/23 2.Date of the original announcement and reporting:2022/05/06 3.Summary of the content originally announced and reported: (1)Trading counterparty: Century Biotech Development Corporation (2)Underlying asset: 5th …
Announcement of not Distributing Dividends in 2022
1.Date of the board of directors resolution:2023/03/13 2.Year or quarter which dividends belong to :2022 3.Period which dividends belong to:2022/1/1 to 2022/12/31 4.Appropriations of earnings in cash dividends to shareholders …
The Company’s BOD resolved the plan to disperse shareholding of Obigen Pharma Inc.
1.Date of occurrence of the event:2023/03/13 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios: N/A 5.Cause of occurrence: To …
Announcement for the appointment of Corporate Governance Officer of the Company
1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development …